Keyphrases
Plasmodium Falciparum
100%
New Drug Candidate
100%
Poly-L-lysine
100%
Basic Peptide
100%
Lysine Peptide
66%
Mass Spectrometry
33%
Malaria
33%
Infected Erythrocytes
33%
Pre-erythrocytic Stages
33%
Affinity Pulldown
33%
Poly(L-lysine) Dendrimer
33%
New Therapeutic Strategies
16%
Adhesion
16%
Flow Cytometry
16%
FDA-approved Drugs
16%
In Vitro Culture
16%
Adaptation
16%
Inhibitory Effect
16%
Lysine Residue
16%
New Therapeutics
16%
Treatment Strategy
16%
Treatment Efficacy
16%
Drug Delivery
16%
Parasitemia
16%
Amodiaquine
16%
Antimalarial Drugs
16%
Parasite Growth
16%
Outer Membrane Protein
16%
Human Erythrocytes
16%
PEGylation
16%
Parasite Clearance
16%
Fast-acting
16%
Lumefantrine
16%
Mefloquine
16%
Acridine Orange
16%
Artemisinin-based Combination Therapy
16%
Clearance Efficiency
16%
Artemisinin Derivatives
16%
Long-acting Drugs
16%
Pharmacology, Toxicology and Pharmaceutical Science
Plasmodium falciparum
100%
Polylysine
100%
Dendrimer
25%
Infection
12%
Combination Therapy
12%
Flow Cytometry
12%
Lysine
12%
Parasitemia
12%
Amodiaquine
12%
Antimalarial Agent
12%
PEGylation
12%
Benflumetol
12%
Mefloquine
12%
Outer Membrane Protein
12%
Artemisinin
12%
Parasite Clearance
12%
Acridine Orange
12%
Artemisinin Derivative
12%